Fulgent Genetics (FLGT) Total Debt (2020 - 2026)

Fulgent Genetics has disclosed Total Debt across 7 years of filings, most recently posting $32.1 million for Q1 2026.

• Total Debt for Q1 2026 came in at $32.1 million, up 8.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.1 million (up 8.24% YoY), and the FY2025 annual result was $30.1 million, changed 0.0% from the prior year.
• Total Debt came in at $32.1 million for Q1 2026 at Fulgent Genetics, up from $30.1 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $32.1 million in Q1 2026 to a low of $14.3 million in Q4 2022.
• The 5-year median for Total Debt is $29.0 million (2022), against an average of $24.5 million.
• Across the five-year window, Total Debt jumped 347.38% in 2022 and tumbled 50.07% in 2023, its largest moves.
• Fulgent Genetics' Total Debt stood at $14.3 million in 2022, then jumped by 79.88% to $25.7 million in 2023, then grew by 17.3% to $30.1 million in 2024, then changed by 0.0% to $30.1 million in 2025, then gained by 6.62% to $32.1 million in 2026.
• The last three Total Debt figures came in at $32.1 million (Q1 2026), $30.1 million (Q4 2025), and $30.5 million (Q3 2025), per Business Quant data.